Macrogen adopts Roche's next-gen platform to speed up genome sequencing
Predicted impact: Low· Actual: +2.9% vs sector, volume 0.9× normal (5 trading days)
Sequencing platform adoption is a small commercial partnership with no size given.
Predicted impact: Low· Actual: +2.9% vs sector, volume 0.9× normal (5 trading days)
Sequencing platform adoption is a small commercial partnership with no size given.
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.